CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
7.21
+0.26 (3.82%)
At close: Aug 8, 2025, 4:00 PM
7.24
+0.04 (0.49%)
After-hours: Aug 8, 2025, 4:10 PM EDT
Heartland Financial USA Market Cap
CVRx, Inc. has a market cap or net worth of $188.42 million as of August 8, 2025. Its market cap has decreased by -7.18% in one year.
Market Cap
188.42M
Enterprise Value
144.86M
1-Year Change
-7.18%
Ranking
Category
Stock Price
$7.21
Market Cap Chart
Since the IPO on June 30, 2021, CVRx, Inc.'s market cap has decreased from $347.31M to $188.42M, a decrease of -45.75%. That is a compound annual growth rate of -13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 189.34M | -38.41% |
| Dec 31, 2024 | 307.42M | -53.03% |
| Dec 29, 2023 | 654.44M | 73.26% |
| Dec 30, 2022 | 377.72M | 51.75% |
| Dec 31, 2021 | 248.90M | -28.33% |
| Jun 30, 2021 | 347.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |